noom glp-1 rx Microdosing for Weight Loss Noom's GLP-1 Companion Receives Major

Smarter Metabolic Support

Our cartridge platform addresses the rapidly growing demand for GLP-1s, and self-administered injectable therapies under full EU Annex 1 expectations

Results Of the 138,397 patients, 57% received neither SGLT2-I nor GLP-1RA, 17% received both, 20% received SGLT2-I only, and 6% received GLP-1RA only

An extensive breakdown of exactly why the GLP-1 hype is making people with eating disorder/weight stigma histories feel like they can't trust themselves.

Over the past six months, states have been proactive in their consideration or reconsideration of next steps pertaining to coverage of Glucagon-like Peptide (GLP)-1s weight loss medication